Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioavailability of a Formulation of Duloxetine 60 mg Enteric Coated Granules With Regards to Reference Product in Feeding Conditions

NCT04751318 is registered in ClinicalTrials.gov with Laboratorios Andromaco S.A. as lead sponsor.

NCT NCT04751318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04751318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioavailability of a Formulation of Duloxetine 60 mg Enteric Coated Granules With Regards to Reference Product in Feeding Conditions
Lead sponsor
Laboratorios Andromaco S.A.
Phase
Phase 1
Overall status
Completed
Start date
February 27, 2021
Completion date
March 16, 2021
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence